Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Congenital stationary night blindness linked to early and worsening myopia
  • Inherited Retinal Disease

Congenital stationary night blindness linked to early and worsening myopia

Kelsey Moroz

Individuals with congenital stationary night blindness (CSNB) show early and significant progression of myopia, according to a study. The research highlights the need for potential long-term interventions to slow myopia progression in these patients and suggests that CSNB should be considered in the diagnosis of early-onset myopia.

The multicenter, retrospective study included 78 participants with CSNB caused by variants in the CACNA1F, NYX, or TRPM1 genes. Data from at least 6 measurements of spherical equivalent refraction (SER) taken before age 18 were analyzed.

A mixed-effect model to track SER progression over time and evaluate differences between genotypes was used.

Results revealed that all 3 genotypes—CACNA1F, NYX, and TRPM1—demonstrated significant myopic SER at birth, with initial values of -3.076D, -5.511D, and -5.386D, respectively. Furthermore, myopia progression was notable across all genotypes, with annual increases of -0.254D, -0.257D, and -0.326D.

The study also emphasizes the need to consider CSNB in the differential diagnosis for early-onset myopia and calls for further research into effective management strategies.

Reference
Igelman AD, White E, Tayyib A, et al. Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study. Br J Ophthalmol. 2024;bjo-2023-323747. doi: 10.1136/bjo-2023-323747. Epub ahead of print. PMID: 39079892.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Conference Roundup

EVO ICL surgery now FDA-approved for older patients

  • Myopia

Efficacy of low-dose atropine for myopia varies by ethnicity, analysis finds

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon